Cargando…
Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008192/ https://www.ncbi.nlm.nih.gov/pubmed/36889512 http://dx.doi.org/10.1016/j.jinf.2023.03.004 |
_version_ | 1784905702829981696 |
---|---|
author | Bhat, Swati Das, Liza Maheshwari, Deep Badal, Darshan Sarkar, Roman Gupta, Madhu Pandav, Surinder Singh Padhi, Bijaya Kumar Bhadada, Sanjay Kumar Holick, Michael F. Dutta, Pinaki Sachdeva, Naresh Marwaha, Raman Kumar |
author_facet | Bhat, Swati Das, Liza Maheshwari, Deep Badal, Darshan Sarkar, Roman Gupta, Madhu Pandav, Surinder Singh Padhi, Bijaya Kumar Bhadada, Sanjay Kumar Holick, Michael F. Dutta, Pinaki Sachdeva, Naresh Marwaha, Raman Kumar |
author_sort | Bhat, Swati |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10008192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100081922023-03-13 Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial Bhat, Swati Das, Liza Maheshwari, Deep Badal, Darshan Sarkar, Roman Gupta, Madhu Pandav, Surinder Singh Padhi, Bijaya Kumar Bhadada, Sanjay Kumar Holick, Michael F. Dutta, Pinaki Sachdeva, Naresh Marwaha, Raman Kumar J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2023-05 2023-03-06 /pmc/articles/PMC10008192/ /pubmed/36889512 http://dx.doi.org/10.1016/j.jinf.2023.03.004 Text en © 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Bhat, Swati Das, Liza Maheshwari, Deep Badal, Darshan Sarkar, Roman Gupta, Madhu Pandav, Surinder Singh Padhi, Bijaya Kumar Bhadada, Sanjay Kumar Holick, Michael F. Dutta, Pinaki Sachdeva, Naresh Marwaha, Raman Kumar Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial |
title | Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial |
title_full | Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial |
title_fullStr | Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial |
title_full_unstemmed | Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial |
title_short | Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial |
title_sort | effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the chadox1 ncov-19 vaccine: a prospective open-label, placebo-controlled, clinical trial |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008192/ https://www.ncbi.nlm.nih.gov/pubmed/36889512 http://dx.doi.org/10.1016/j.jinf.2023.03.004 |
work_keys_str_mv | AT bhatswati effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT dasliza effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT maheshwarideep effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT badaldarshan effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT sarkarroman effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT guptamadhu effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT pandavsurindersingh effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT padhibijayakumar effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT bhadadasanjaykumar effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT holickmichaelf effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT duttapinaki effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT sachdevanaresh effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial AT marwaharamankumar effectofcalcifediolsupplementationasaddontherapyontheimmunerepertoireinrecipientsofthechadox1ncov19vaccineaprospectiveopenlabelplacebocontrolledclinicaltrial |